- Home
- LRMR vs TEAF Comparison
LRMR vs TEAF Comparison
Compare LRMR & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- TEAF
- Stock Information
- Founded
- LRMR N/A
- TEAF 2017
- Country
- LRMR United States
- TEAF United States
- Employees
- LRMR N/A
- TEAF N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- TEAF Trusts Except Educational Religious and Charitable
- Sector
- LRMR Health Care
- TEAF Finance
- Exchange
- LRMR Nasdaq
- TEAF Nasdaq
- Market Cap
- LRMR 183.8M
- TEAF 152.6M
- IPO Year
- LRMR N/A
- TEAF N/A
- Fundamental
- Price
- LRMR $2.12
- TEAF $11.36
- Analyst Decision
- LRMR Strong Buy
- TEAF
- Analyst Count
- LRMR 9
- TEAF 0
- Target Price
- LRMR $19.00
- TEAF N/A
- AVG Volume (30 Days)
- LRMR 1.4M
- TEAF 56.1K
- Earning Date
- LRMR 04-30-2025
- TEAF 01-01-0001
- Dividend Yield
- LRMR N/A
- TEAF 9.20%
- EPS Growth
- LRMR N/A
- TEAF N/A
- EPS
- LRMR N/A
- TEAF N/A
- Revenue
- LRMR N/A
- TEAF N/A
- Revenue This Year
- LRMR N/A
- TEAF N/A
- Revenue Next Year
- LRMR N/A
- TEAF N/A
- P/E Ratio
- LRMR N/A
- TEAF N/A
- Revenue Growth
- LRMR N/A
- TEAF N/A
- 52 Week Low
- LRMR $1.61
- TEAF $11.11
- 52 Week High
- LRMR $11.20
- TEAF $13.30
- Technical
- Relative Strength Index (RSI)
- LRMR 44.72
- TEAF 54.15
- Support Level
- LRMR $2.03
- TEAF $11.31
- Resistance Level
- LRMR $2.33
- TEAF $11.47
- Average True Range (ATR)
- LRMR 0.30
- TEAF 0.16
- MACD
- LRMR -0.01
- TEAF 0.04
- Stochastic Oscillator
- LRMR 11.21
- TEAF 71.15
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About TEAF Ecofin Sustainable and Social Impact Term Fund
Tortoise Essential Assets Income Term is a USA-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.